Brian Wayment - Pennant President Healthcare

PNTG Stock  USD 30.50  0.28  0.91%   

President

Brian Wayment is President Healthcare of Pennant Group
Address 1675 East Riverside Drive, Eagle, ID, United States, 83616
Phone208 506 6100
Webhttps://www.pennantgroup.com

Pennant Management Efficiency

The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1367 %, meaning that it created $0.1367 on every $100 dollars invested by stockholders. Pennant's management efficiency ratios could be used to measure how well Pennant manages its routine affairs as well as how well it operates its assets and liabilities. The Pennant's current Return On Equity is estimated to increase to 0.13, while Return On Tangible Assets are projected to decrease to 0.03. At this time, Pennant's Asset Turnover is most likely to slightly decrease in the upcoming years.
Pennant Group currently holds 329.63 M in liabilities with Debt to Equity (D/E) ratio of 2.66, implying the company greatly relies on financing operations through barrowing. Pennant Group has a current ratio of 0.98, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Pennant's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Faisal KhanModivCare
N/A
Ilias SimpsonModivCare
40
Barbara JacobsmeyerEncompass Health Corp
55
Anne BaileyModivCare
51
Edmund FayEncompass Health Corp
54
Bryan McCartneyHealthcare Services Group
63
Jerry GrayEncompass Health Corp
N/A
Marc MillerUniversal Health Services
53
Kevin ReeseThe Ensign Group
N/A
Eric EvansSurgery Partners
47
Anthony TaparoSurgery Partners
58
Douglas ColtharpEncompass Health Corp
62
Patrick DarbyEncompass Health Corp
56
Jennifer BaldockSurgery Partners
53
Marvin PemberUniversal Health Services
66
Steve FiltonUniversal Health Services
66
Peter MantegazzaEncompass Health Corp
N/A
Harrison BaneSurgery Partners
37
Bradley OwensSurgery Partners
54
Spencer BurtonThe Ensign Group
45
Linda WilderEncompass Health Corp
N/A
The Pennant Group, Inc. provides healthcare services in the United States. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho. Pennant operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 6441 people. Pennant Group (PNTG) is traded on NASDAQ Exchange in USA. It is located in 1675 East Riverside Drive, Eagle, ID, United States, 83616 and employs 5,791 people. Pennant is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Pennant Group Leadership Team

Elected by the shareholders, the Pennant's board of directors comprises two types of representatives: Pennant inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pennant. The board's role is to monitor Pennant's management team and ensure that shareholders' interests are well served. Pennant's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pennant's outside directors are responsible for providing unbiased perspectives on the board's policies.
Derek Bunker, Exec Officer
Brian Wayment, President Healthcare
Jason Steik, Chief Officer
Kirk Cheney, General Secretary
Brent Guerisoli, Chief Officer
Jennifer CPA, Chief Officer
Lynette CPA, Chief Officer
John Gochnour, Chief Officer

Pennant Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pennant a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Pennant Group is a strong investment it is important to analyze Pennant's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pennant's future performance. For an informed investment choice regarding Pennant Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pennant Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pennant. If investors know Pennant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pennant listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.365
Earnings Share
0.68
Revenue Per Share
21.663
Quarterly Revenue Growth
0.289
Return On Assets
0.0383
The market value of Pennant Group is measured differently than its book value, which is the value of Pennant that is recorded on the company's balance sheet. Investors also form their own opinion of Pennant's value that differs from its market value or its book value, called intrinsic value, which is Pennant's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pennant's market value can be influenced by many factors that don't directly affect Pennant's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pennant's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pennant is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pennant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.